ABPI Cymru Wales

ABPI Cymru Wales was established in 2003 in response to the evolving distinctiveness of the post-devolution health and economic agenda in Wales.

ABPI Cymru Wales and its members work collaboratively with Welsh Government, NHS Wales, Patient Organisations, the Welsh Parliament and other key stakeholders to help address the health needs of the people of Wales.

Wales Board Sponsored Group

We support the work of the ABPI Cymru Wales Board Sponsored Group (WBSG), a collaboration of ABPI members with a declared interest in Wales. WBSG currently has a membership of over thirty ABPI member companies, including both major global companies and smaller companies with a strong presence in Wales.

Our Wales Board Sponsored Group ensures that medicines promotion and collaborative working with the NHS are conducted in an open, responsible, and ethical way.

ABPI Cymru Wales Bulletin

As we draw towards the end of the 2023 summer break, we wanted to share our ABPI Cymru Wales Summer Bulletin with you.

This is the 37th edition of the ABPI Cymru Wales Bulletin. As ever, it is a diverse mix of articles and updates, including one focused on why the availability of new medicines depends on access to health data, and another on the importance of genomics to the future of healthcare.

Read the ABPI Cymru Wales Summer Bulletin 2023

Life Sciences

Wales hosts 20% more life sciences businesses than the UK average, ranging from pioneering SMEs and start-ups to global blue-chip corporations. Combined, the sector employs over 11,000 people and contributes over £2 billion in turnover to the Welsh economy.

With our members, we work alongside healthcare professionals and patients under the strict governance arrangements of the ABPI Code of Practice.